Trial Outcomes & Findings for Ocular Effects of Scleral Lens Wear on Dry Eye Patients (NCT NCT05079321)
NCT ID: NCT05079321
Last Updated: 2025-05-06
Results Overview
Mean corneal thickness as measured with Pentacam HR (µm)
COMPLETED
NA
30 participants
At screening
2025-05-06
Participant Flow
Participants were recruited at a single site between April 2022 and October 2022. The first participant was enrolled on April 14, 2022 and the last participant was enrolled on October 25, 2022.
Of 30 enrolled participants, 28 met inclusion criteria and 25 were randomized to treatment.
Participant milestones
| Measure |
Coated/Uncoated Scleral Lens
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Overall Study
STARTED
|
12
|
13
|
|
Overall Study
COMPLETED
|
10
|
10
|
|
Overall Study
NOT COMPLETED
|
2
|
3
|
Reasons for withdrawal
| Measure |
Coated/Uncoated Scleral Lens
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
2
|
2
|
|
Overall Study
Lost to Follow-up
|
0
|
1
|
Baseline Characteristics
Ocular Effects of Scleral Lens Wear on Dry Eye Patients
Baseline characteristics by cohort
| Measure |
Overall Group
n=28 Participants
All suitable participants eligible to take part in the study.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
28 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
28.79 years
STANDARD_DEVIATION 7.61 • n=5 Participants
|
|
Sex: Female, Male
Female
|
24 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Asian
|
12 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Caucasian
|
8 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · African/Black
|
2 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Indian
|
4 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Arab
|
2 Participants
n=5 Participants
|
|
Region of Enrollment
Canada
|
28 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: At screeningMean corneal thickness as measured with Pentacam HR (µm)
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=12 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=13 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Mean Corneal Thickness
|
570.54 microns
Standard Deviation 38.97
|
560.73 microns
Standard Deviation 31.48
|
PRIMARY outcome
Timeframe: After 4 weeks wear of coated lensMean corneal thickness as measured with Pentacam HR (µm)
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Mean Corneal Thickness
|
552.70 microns
Standard Deviation 26.96
|
559.85 microns
Standard Deviation 35.31
|
PRIMARY outcome
Timeframe: After 4 weeks wear of uncoated lensMean corneal thickness as measured with Pentacam HR (µm)
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Mean Corneal Thickness
|
556.91 microns
Standard Deviation 29.83
|
556.87 microns
Standard Deviation 29.92
|
PRIMARY outcome
Timeframe: After 2 weeks of wear of coated lensThe CLDEQ-8 is a validated questionnaire used to quantify symptoms experienced by the contact lenses (CLs) wearer. The participants were asked to respond to 8 questions about how their CLs performed over the preceding 2-week period. 4 questions (Eye discomfort, Eye dryness, Changeable blurry vision and Closing your eyes) answered on a scale of 0=Never to 4=Constantly; 3 questions about the end of wearing time (Discomfort, Dryness, Changeable blurry vision) answered on a scale of 0=Never have it to 5=Very Intense and 1 question (Removing your lenses) on a scale of 1=Never to 6=Several times a day for a total possible score of 1(best) to 37 (worst).
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Contact Lens Dry Eye Questionnaire (CLDEQ-8) Score
|
14.10 score on a scale
Standard Deviation 7.92
|
20.30 score on a scale
Standard Deviation 5.56
|
PRIMARY outcome
Timeframe: After 2 weeks of wear of uncoated lensThe CLDEQ-8 is a validated questionnaire used to quantify symptoms experienced by the contact lenses (CLs) wearer. The participants were asked to respond to 8 questions about how their CLs performed over the preceding 2-week period. 4 questions (Eye discomfort, Eye dryness, Changeable blurry vision and Closing your eyes) answered on a scale of 0=Never to 4=Constantly; 3 questions about the end of wearing time (Discomfort, Dryness, Changeable blurry vision) answered on a scale of 0=Never have it to 5=Very Intense and 1 question (Removing your lenses) on a scale of 1=Never to 6=Several times a day for a total possible score of 1(best) to 37 (worst).
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Contact Lens Dry Eye Questionnaire (CLDEQ-8) Score
|
19.40 score on a scale
Standard Deviation 7.34
|
17.20 score on a scale
Standard Deviation 6.55
|
PRIMARY outcome
Timeframe: After 4 weeks of wear of coated lensThe CLDEQ-8 is a validated questionnaire used to quantify symptoms experienced by the contact lenses (CLs) wearer. The participants were asked to respond to 8 questions about how their CLs performed over the preceding 2-week period. 4 questions (Eye discomfort, Eye dryness, Changeable blurry vision and Closing your eyes) answered on a scale of 0=Never to 4=Constantly; 3 questions about the end of wearing time (Discomfort, Dryness, Changeable blurry vision) answered on a scale of 0=Never have it to 5=Very Intense and 1 question (Removing your lenses) on a scale of 1=Never to 6=Several times a day for a total possible score of 1(best) to 37 (worst).
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Contact Lens Dry Eye Questionnaire (CLDEQ-8) Score
|
13.50 score on a scale
Standard Deviation 7.07
|
19.50 score on a scale
Standard Deviation 6.64
|
PRIMARY outcome
Timeframe: After 4 weeks of wear of uncoated lensThe CLDEQ-8 is a validated questionnaire used to quantify symptoms experienced by the contact lenses (CLs) wearer. The participants were asked to respond to 8 questions about how their CLs performed over the preceding 2-week period. 4 questions (Eye discomfort, Eye dryness, Changeable blurry vision and Closing your eyes) answered on a scale of 0=Never to 4=Constantly; 3 questions about the end of wearing time (Discomfort, Dryness, Changeable blurry vision) answered on a scale of 0=Never have it to 5=Very Intense and 1 question (Removing your lenses) on a scale of 1=Never to 6=Several times a day for a total possible score of 1(best) to 37 (worst).
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Contact Lens Dry Eye Questionnaire (CLDEQ-8) Score
|
18.60 score on a scale
Standard Deviation 7.99
|
15.10 score on a scale
Standard Deviation 7.65
|
PRIMARY outcome
Timeframe: At screeningTear film osmolarity measures with a Tearlab Osmolarity System
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=12 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=13 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Tear Film Osmolarity
|
313.29 mOsm/l
Standard Deviation 22.18
|
309.69 mOsm/l
Standard Deviation 16.32
|
PRIMARY outcome
Timeframe: After 4 weeks of wear of uncoated lensTear film osmolarity measures with a Tearlab Osmolarity System
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Tear Film Osmolarity
|
300.00 mOsm/l
Standard Deviation 12.87
|
306.05 mOsm/l
Standard Deviation 12.87
|
PRIMARY outcome
Timeframe: After 4 weeks of wear of coated lensTear film osmolarity measures with a Tearlab Osmolarity System
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Tear Film Osmolarity
|
304.40 mOsm/l
Standard Deviation 8.48
|
303.90 mOsm/l
Standard Deviation 11.57
|
PRIMARY outcome
Timeframe: After 4 weeks of wear of uncoated lensThis self-administered Contact Lens Impact on Quality of Life (CLIQ) questionnaire uses 28-item questions which are categorized into five main parameters: daily activities, eye symptoms, functional vision, psychometric properties, and refractive correction. Each question has a five-step response scale (none = 1; little = 2; moderate = 3; extreme = 4 and unable = 5). The responses are computed using the formula: CLIQperson measure = 34.41 × log (CLIQraw score/5 - CLIQraw score) + 26.69. This is then analyzed on a scale from 0 to 100, where higher scores indicate better QoL.
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Contact Lens Impact on Quality of Life (CLIQ) Questionnaire Score
|
37.66 score on a scale
Standard Deviation 13.37
|
39.67 score on a scale
Standard Deviation 9.78
|
PRIMARY outcome
Timeframe: After 4 weeks of wear of coated lensThis self-administered Contact Lens Impact on Quality of Life (CLIQ) questionnaire uses 28-item questions which are categorized into five main parameters: daily activities, eye symptoms, functional vision, psychometric properties, and refractive correction. Each question has a five-step response scale (none = 1; little = 2; moderate = 3; extreme = 4 and unable = 5). The responses are computed using the formula: CLIQperson measure = 34.41 × log (CLIQraw score/5 - CLIQraw score) + 26.69. This is then analyzed on a scale from 0 to 100, where higher scores indicate better QoL.
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Contact Lens Impact on Quality of Life (CLIQ) Questionnaire Score
|
40.70 score on a scale
Standard Deviation 9.49
|
40.54 score on a scale
Standard Deviation 11.31
|
PRIMARY outcome
Timeframe: At screeningPercentage of participants with a positive MMP-9 test, as measured by InflammaDry
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=12 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=13 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Percentage of Participants With MMP-9 Inflammatory Marker in Tear Film
|
83.33 percentage of participants
|
84.62 percentage of participants
|
PRIMARY outcome
Timeframe: After 4 weeks of wear of coated lensPercentage of participants with a positive MMP-9 test, as measured by InflammaDry
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Percentage of Participants With MMP-9 Inflammatory Marker in Tear Film
|
80 percentage of participants
|
70 percentage of participants
|
PRIMARY outcome
Timeframe: After 4 weeks of wear of uncoated lensPercentage of participants with a positive MMP-9 test, as measured by InflammaDry
Outcome measures
| Measure |
Coated/Uncoated Scleral Lens
n=10 Participants
Participants wear first wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
Participants then wear uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated)
|
Uncoated/Coated Scleral Lens
n=10 Participants
Participants wear first uncoated (control) lenses.
Uncoated: Zen™ RC scleral lenses (non-coated
Participants wear then wear lenses coated with Hydra-PEG.
Hydra-PEG: Zen™ RC scleral lenses (Hydra-PEG coated)
|
|---|---|---|
|
Percentage of Participants With MMP-9 Inflammatory Marker in Tear Film
|
50 percentage of participants
|
60 percentage of participants
|
Adverse Events
Coated Scleral Lens
Uncoated Scleral Lens
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Lyndon Jones
Centre for Ocular Research and Education
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place